Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fanghua Huang"'
Autor:
Liyuan Zhao, Zixuan Yang, Minhui Zheng, Lei Shi, Mengyun Gu, Gang Liu, Feng Miao, Yan Chang, Fanghua Huang, Naping Tang
Publikováno v:
Genes and Diseases, Vol 11, Iss 1, Pp 283-293 (2024)
In recent years, significant breakthroughs have been made in the field of gene therapy. Adeno-associated virus (AAV) is one of the most promising gene therapy vectors and a powerful tool for delivering the gene of interest. Among the AAV vectors, AAV
Externí odkaz:
https://doaj.org/article/a4c93636d99a4c9aa9530275324e168d
Autor:
Liyuan Zhao, Zixuan Yang, Minhui Zheng, Lei Shi, Mengyun Gu, Gang Liu, Feng Miao, Yan Chang, Fanghua Huang, Naping Tang
Publikováno v:
Genes & Diseases.
Autor:
Yan Chang, Bojun Yuan, Xin Wang, Yang Luan, Changhui Zhou, Qingli Wang, Xingchao Geng, Na Wei, Jiangbo Zhu, Mingyang Liao, Ming Zhang, Jing Ma, Zhaomin Zhong, Fanghua Huang, Jinbao Yu, Zhongchun Zhang, Fengjun An, Zhenna Xia, Ying Jiang, Yongsheng Yu, Tianbao Zhang, Dorothea K. Torous, Qing Ju, Chang Shi, Hongling Wang, Yiyi Cao, Stephen D. Dertinger, Bo Li
Publikováno v:
Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 772:6-13
Although inter-laboratory validation efforts of the in-vivo micronucleus (MN) assay based on flow cytometry (FCM) have taken place in the EU and US, none have been organized in China. Therefore, an inter-laboratory study that included eight laborator
Publikováno v:
Drug Discovery and Evaluation: Pharmacological Assays ISBN: 9783642277283
Drug Discovery and Evaluation: Pharmacological Assays ISBN: 9783319053912
Drug Discovery and Evaluation: Pharmacological Assays ISBN: 9783319053912
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee27224b82e12f3763d8ae514d725331
https://doi.org/10.1007/978-3-642-27728-3_119-1
https://doi.org/10.1007/978-3-642-27728-3_119-1
Autor:
Fanghua Huang
Publikováno v:
China Journal of Chinese Matera Medica. 35
Pharmacokinetics study is one of main components of pharmaceuticals development. Food and Drug Administration (FDA) approved Veregen as the first botanical drug in 2006. This article introduced FDA's requirement on pharmacokinetics study of botanical